The Australian Self Medication Industry (ASMI) is calling for IP protection for successful prescription-to-OTC reclassification applications to encourage switching in Australia.
The Australian Self Medication Industry (ASMI) has called for greater measures to protect intellectual property (IP) investment within the country’s prescription-to-OTC reclassification application process.
Forming part of its ‘2019-20 Pre-Budget Submission,’ the ASMI recommended to the Australian Treasury that the country’s medicines regulation should...
The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”
If the European Commission is serious about improving the competitiveness of the European Union, it should ditch the idea of making commonly used OTC antimicrobials like thrush treatments and cold sore creams prescription-only, warns Greek Medicines Agency president Evangelos Manolopoulos
HBW Insight speaks to NèreS' executive director Luc Besançon about the key issues facing France's self-care industry, especially Rx-to-OTC switch and the revised Urban Wastewater Treatment Directive.
Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.
